首页> 外文会议>Southern Biomedical Engineering Conference >Application of a Fluorescent Multiple Indicator Method to Study Changes in Cardiac Permeafbility with Chemotherapy
【24h】

Application of a Fluorescent Multiple Indicator Method to Study Changes in Cardiac Permeafbility with Chemotherapy

机译:荧光多重指示法在化疗中研究心脐率的研究变化

获取原文

摘要

Classical measurements of tissue permeability use radioactive indicators, which are very accurate but also limited by radiation exposure hazards. We have developed a fluorescent multiple indicator dilution method using Texas Red-conjugated Dextran (TR, MW 70,000 Da) as the reference dye, and sodium fluorescein (NaFL, MW 376 Da) as the diffusible dye. The characteristic excitation/emission wavelengths are 485/515 nm for NaFL, and 590/630 nm for TR. By comparing the output profiles of the two dyes versus time using a spectrofluorometer, we can estimate the permeability-surface-area-product (PSP) of the capillary network. We have studied changes in cardiac capillary permeability after treatment with doxorubicin (DOX) using our method. Our hypothesis is that DOX treatment will cause endothelial damage and lead to increased cardiac capillary permeability. Sprague-Dawley rats were randomly assigned to a control (n= 4) or DOX group (n = 5). Rats were injected intraperitoneally with 3 mg/kg of either saline solution or DOX on days 1, 3, 5, 7, 9, and 11. On day 12, we performed the isolated heart experiment. In three replicates, we injected 25 u.L of the fluorescent mixture above the aortic cannula (12.5 uL each of 1.56 ug/mL TR, 1.56 ng/niL NaFL), and collected output samples for 45 seconds. We measured the samples using a Fluorolog-3~R spectrofluorometer. The results showed that the control group had a lower average PSP (0.04±0.01 cm~3/s) than the DOX group (0.09±0.01 cm~3/s), p<0.05. This indicates that DOX treatment causes an increase in cardiac capillary permeability related to its cardiotoxic effects. The results also show that our fluorescent indicator dilution method is able to sensitively detect changes in cardiac capillary permeability. The applicability of this method is not limited to the isolated heart setup, and the protocol can be adapted for use in other studies of organ or tissue permeability.
机译:组织渗透性的经典测量使用放射性指标,这非常准确,但也受辐射暴露危害的限制。我们开发了使用德克萨斯红缀合的葡聚糖(TR,MW 70,000Da)作为参考染料的荧光多种指示稀释方法,以及荧光素(NAFL,MW 376Da)作为扩散染料。特征激发/发射波长为NAFL为485/515nm,TR的590/630nm为590/630nm。通过使用光谱荧光计比较两种染料与时间的输出曲线,我们可以估计毛细管网络的渗透性 - 表面积 - 产品(PSP)。我们使用我们的方法研究了用多柔比星(DOX)处理后心脏毛细血管渗透性的变化。我们的假设是Dox治疗将导致内皮损伤并导致心脏毛细血管渗透率增加。 Sprague-Dawley大鼠随机分配给对照(n = 4)或DOX组(n = 5)。在第1天,3,5,7,9和11天腹膜内用3mg / kg盐酸溶液或DOX注射大鼠。在第12天,我们进行了孤立的心脏实验。在三次重复中,我们注射了25u.1的主动脉​​套管上方的荧光混合物(12.5μl1.56μg/ ml Tr,1.56 ng /毫升NAFL),并收集输出样品45秒。我们使用氟-3〜R光谱荧光计测量样品。结果表明,对照组的平均PSP(0.04±0.01cm〜3 / s)比DOX组(0.09±0.01cm〜3 / s),P <0.05。这表明DOX治疗导致与其心脏毒性效应相关的心脏毛细血管渗透性增加。结果还表明,我们的荧光指示剂稀释方法能够灵敏地检测心肌毛细血管渗透性的变化。该方法的适用性不限于分离的心脏设置,方案可以适用于器官或组织渗透性的其他研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号